Trial Profile
A Phase I Study of Herceptin/Flavopiridol in HER-2 Positive Metastatic Breast Cancer
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Alvocidib (Primary) ; Trastuzumab (Primary)
- Indications Advanced breast cancer; Male breast cancer
- Focus Adverse reactions; Biomarker
- 07 Feb 2013 New trial record